scispace - formally typeset
J

Jolanda M. A. Boer

Researcher at Centre for Health Protection

Publications -  178
Citations -  12179

Jolanda M. A. Boer is an academic researcher from Centre for Health Protection. The author has contributed to research in topics: Population & Cohort study. The author has an hindex of 48, co-authored 164 publications receiving 10345 citations.

Papers
More filters
Journal ArticleDOI

Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study

Benjamin F. Voight, +140 more
TL;DR: In this paper, a Mendelian randomisation analysis was performed to compare the effect of HDL cholesterol, LDL cholesterol, and genetic score on risk of myocardial infarction.

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

Benjamin F. Voight, +125 more
TL;DR: Mendelian randomisation analyses challenge the concept that raising of plasma HDL cholesterol will uniformly translate into reductions in risk of myocardial infarction.
Journal ArticleDOI

Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies

Angela M. Wood, +132 more
- 14 Apr 2018 - 
TL;DR: Current drinkers of alcohol in high-income countries, the threshold for lowest risk of all-cause mortality was about 100 g/week, and data support limits for alcohol consumption that are lower than those recommended in most current guidelines.
Journal ArticleDOI

Identification of heart rate–associated loci and their effects on cardiac conduction and rhythm disorders

Marcel den Hoed, +267 more
- 01 Jun 2013 - 
TL;DR: A 2-stage meta-analysis of genome-wide association studies in up to 181,171 individuals identified 14 new loci associated with heart rate and confirmed associations with all 7 previously established loci, providing fresh insights into the mechanisms regulating heart rate.
Journal ArticleDOI

SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

Steven H J Hageman, +174 more
TL;DR: In this article, the authors developed, validated, and illustrated an updated prediction model (SCORE2) to estimate 10-year fatal and non-fatal cardiovascular disease (CVD) risk in individuals without previous CVD or diabetes aged 40-69 years in Europe.